Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc.
🏛 Food and Drug Administration (FDA)FDA-2026-N-4162
Documents
1
Total comments
4
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Notice· May 22, 2026Closing soon · 4 days left💬 4